# IDRSemi Strategic Analysis: Pacetronix vs RISC-V

## Option 1: Pacetronix (Medical ASIC)
### Pros
- Immediate revenue opportunity
- High-value medical market
- Clear customer requirements
- Regulatory experience valuable
- Recurring business potential

### Cons
- Strict FDA/medical compliance
- Long development cycles
- High liability concerns
- Conservative technology choices
- Limited IP ownership

## Option 2: RISC-V Development
### Pros
- Full IP ownership
- Trendy technology
- Multiple market opportunities
- Open ecosystem
- Design freedom

### Cons
- No immediate customer
- Crowded market
- Longer path to revenue
- Need differentiation
- Marketing challenge

## Recommendation
Start with Pacetronix for cash flow, develop RISC-V in parallel